These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30024736)

  • 1. Conserved S/T Residues of the Human Chaperone DNAJB6 Are Required for Effective Inhibition of Aβ42 Amyloid Fibril Formation.
    Månsson C; van Cruchten RTP; Weininger U; Yang X; Cukalevski R; Arosio P; Dobson CM; Knowles T; Akke M; Linse S; Emanuelsson C
    Biochemistry; 2018 Aug; 57(32):4891-4902. PubMed ID: 30024736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (Aβ42) aggregates leads to sub-stoichiometric inhibition of amyloid formation.
    Månsson C; Arosio P; Hussein R; Kampinga HH; Hashem RM; Boelens WC; Dobson CM; Knowles TP; Linse S; Emanuelsson C
    J Biol Chem; 2014 Nov; 289(45):31066-76. PubMed ID: 25217638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-β oligomers are captured by the DNAJB6 chaperone: Direct detection of interactions that can prevent primary nucleation.
    Österlund N; Lundqvist M; Ilag LL; Gräslund A; Emanuelsson C
    J Biol Chem; 2020 Jun; 295(24):8135-8144. PubMed ID: 32350108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-terminal domain of the antiamyloid chaperone DNAJB6 binds to amyloid-β peptide fibrils and inhibits secondary nucleation.
    Österlund N; Frankel R; Carlsson A; Thacker D; Karlsson M; Matus V; Gräslund A; Emanuelsson C; Linse S
    J Biol Chem; 2023 Nov; 299(11):105317. PubMed ID: 37797698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural modelling of the DNAJB6 oligomeric chaperone shows a peptide-binding cleft lined with conserved S/T-residues at the dimer interface.
    Söderberg CAG; Månsson C; Bernfur K; Rutsdottir G; Härmark J; Rajan S; Al-Karadaghi S; Rasmussen M; Höjrup P; Hebert H; Emanuelsson C
    Sci Rep; 2018 Mar; 8(1):5199. PubMed ID: 29581438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios.
    Månsson C; Kakkar V; Monsellier E; Sourigues Y; Härmark J; Kampinga HH; Melki R; Emanuelsson C
    Cell Stress Chaperones; 2014 Mar; 19(2):227-39. PubMed ID: 23904097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain.
    Zhong X; Kumar R; Wang Y; Biverstål H; Ingeborg Jegerschöld C; J B Koeck P; Johansson J; Abelein A; Chen G
    ACS Chem Biol; 2022 Aug; 17(8):2201-2211. PubMed ID: 35876740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ability of DNAJB6b to Suppress Amyloid Formation Depends on the Chaperone Aggregation State.
    Carlsson A; Axell E; Emanuelsson C; Olsson U; Linse S
    ACS Chem Neurosci; 2024 May; 15(9):1732-1737. PubMed ID: 38640082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin.
    Raman B; Ban T; Sakai M; Pasta SY; Ramakrishna T; Naiki H; Goto Y; Rao ChM
    Biochem J; 2005 Dec; 392(Pt 3):573-81. PubMed ID: 16053447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human DnaJB6 Antiamyloid Chaperone Protects Yeast from Polyglutamine Toxicity Separately from Spatial Segregation of Aggregates.
    Kumar J; Kline NL; Masison DC
    Mol Cell Biol; 2018 Dec; 38(23):. PubMed ID: 30224519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
    Abelein A; Gräslund A; Danielsson J
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides.
    Gillis J; Schipper-Krom S; Juenemann K; Gruber A; Coolen S; van den Nieuwendijk R; van Veen H; Overkleeft H; Goedhart J; Kampinga HH; Reits EA
    J Biol Chem; 2013 Jun; 288(24):17225-37. PubMed ID: 23612975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative NMR analysis of the mechanism and kinetics of chaperone Hsp104 action on amyloid-β42 aggregation and fibril formation.
    Ghosh S; Tugarinov V; Clore GM
    Proc Natl Acad Sci U S A; 2023 May; 120(21):e2305823120. PubMed ID: 37186848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smallest Secondary Nucleation Competent Aβ Aggregates Probed by an ATP-Independent Molecular Chaperone Domain.
    Leppert A; Tiiman A; Kronqvist N; Landreh M; Abelein A; Vukojević V; Johansson J
    Biochemistry; 2021 Mar; 60(9):678-688. PubMed ID: 33621049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
    Dong M; Zhao W; Hu D; Ai H; Kang B
    ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
    De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
    J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Reorganization Mechanism of the Aβ
    Dabas A; Goyal B
    ACS Chem Neurosci; 2024 Sep; 15(17):3136-3151. PubMed ID: 39158263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulations on the dual effects of flavonoids as suppressors of Aβ42 fibrillogenesis and destabilizers of mature fibrils.
    Gargari SA; Barzegar A
    Sci Rep; 2020 Oct; 10(1):16636. PubMed ID: 33024142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.